These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8465405)

  • 1. Activity in vitro of the enantiomers of halofantrine.
    Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J
    Trans R Soc Trop Med Hyg; 1993; 87(1):78-9. PubMed ID: 8465405
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.
    Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J
    Br J Clin Pharmacol; 1992 May; 33(5):517-20. PubMed ID: 1524966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the enantiomers of N-desbutyl derivative of halofantrine.
    Basco LK; Peytavin G; Gimenez F; Genissel B; Farinotti R; Le Bras J
    Trop Med Parasitol; 1994 Mar; 45(1):45-6. PubMed ID: 8066381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity of southern African isolates of Plasmodium falciparum to halofantrine.
    Freese JA; Rossouw EJ; Gouws E; Sharp BL; Markus MB
    Ann Trop Med Parasitol; 1993 Jun; 87(3):235-9. PubMed ID: 8257233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced in vitro susceptibility to halofantrine of Plasmodium falciparum in West Africa.
    Ringwald P; LeBras J; Voyer C; Coulaud JP
    Lancet; 1990 Feb; 335(8686):421-2. PubMed ID: 1968157
    [No Abstract]   [Full Text] [Related]  

  • 6. Halofantrine sensitivity.
    Wildling E; Winkler S; Brandts C; Jenne L; Graninger W; Wernsdorfer WH; Bienzle U; Kremsner PG
    Lancet; 1993 Jul; 342(8862):55-6. PubMed ID: 8100329
    [No Abstract]   [Full Text] [Related]  

  • 7. Halofantrine resistance in African countries.
    Carme B; Gay F; Hayette MP; Diquet B; Danis M
    Lancet; 1993 May; 341(8855):1282-3. PubMed ID: 8098424
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug sensitivity of Plasmodium falciparum in Madagascar. V. Study of the in vitro activity of quinine, mefloquine and halofantrine].
    Deloron P; Le Bras J; Coulanges P; Coulaud JP
    Arch Inst Pasteur Madagascar; 1984; 51(1):81-7. PubMed ID: 6398676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofantrine resistance in African countries.
    Basco LK
    Lancet; 1993 May; 341(8855):1283. PubMed ID: 8098425
    [No Abstract]   [Full Text] [Related]  

  • 10. Fast emergence of Plasmodium falciparum resistance to halofantrine.
    Brasseur P; Bitsindou P; Moyou RS; Eggelte TA; Samba G; Penchenier L; Druilhe P
    Lancet; 1993 Apr; 341(8849):901-2. PubMed ID: 8096608
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimalarial activity in vitro of the N-desbutyl derivative of halofantrine.
    Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J
    Trans R Soc Trop Med Hyg; 1992; 86(1):12-3. PubMed ID: 1566290
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-resistance between mefloquine and halofantrine.
    Gay F; Bustos DG; Diquet B; Rojas Rivero L; Litaudon M; Pichet C; Danis M; Gentilini M
    Lancet; 1990 Nov; 336(8725):1262. PubMed ID: 1978108
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).
    Ouédraogo JB; Dutheil Y; Tinto H; Traoré B; Zampa H; Tall F; Coulibaly SO; Guiguemdé TR
    Trop Med Int Health; 1998 May; 3(5):381-4. PubMed ID: 9623943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short report: in vivo sensitivity of Plasmodium falciparum to halofantrine in southern central Vietnam.
    Doan HN; Taylor WR; Nguyen DT; Tran TU; Fryauff DJ; Susanti I; Gómez-Saladín E; Le DC; Baird JK
    Am J Trop Med Hyg; 2003 Nov; 69(5):553-4. PubMed ID: 14695095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Plasmodium falciparum isolates to halofantrine in the Central Province of Papua New Guinea.
    Hombhanje FW; Kereu RK
    P N G Med J; 1998 Mar; 41(1):30-6. PubMed ID: 10741175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model.
    Singh N; Puri SK
    Life Sci; 2000 Aug; 67(11):1345-54. PubMed ID: 10972203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type RI resistance to halofantrine in West Africa.
    Basco LK; Le Bras J; Gillotin C; Ringwald P; Rabenjarson E; Gimenez F; Bouchaud O; Farinotti R; Coulaud JP
    Trop Med Parasitol; 1991 Dec; 42(4):413-4. PubMed ID: 1665577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents.
    Karle JM; Olmeda R; Gerena L; Milhous WK
    Exp Parasitol; 1993 Jun; 76(4):345-51. PubMed ID: 8513873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of multiresistant Plasmodium falciparum to new candidate antimalarial drugs in western Thailand.
    Schildbach S; Wernsdorfer WH; Suebsaeng L; Rooney W
    Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):29-38. PubMed ID: 2205926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.